LUCD
$1.38-0.02 (-1.43%)
Lucid Diagnostics Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and canc...
Recent News
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates
908 Devices (MASS) delivered earnings and revenue surprises of +11.82% and +4.07%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Veracyte (VCYT) Q4 Earnings and Revenues Surpass Estimates
Veracyte (VCYT) delivered earnings and revenue surprises of +30.06% and +1.41%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Orthofix (OFIX) Q4 Earnings and Revenues Lag Estimates
Orthofix (OFIX) delivered earnings and revenue surprises of -40.91% and -0.22%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Inogen (INGN) Soars 6.6%: Is Further Upside Left in the Stock?
Inogen (INGN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Lucid Diagnostics Insider Ups Holding By 162% During Year
Viewing insider transactions for Lucid Diagnostics Inc.'s ( NASDAQ:LUCD ) over the last year, we see that insiders were...